Viatris Closes $36.50-Per-Share Pacira Acquisition
Viatris closed its $36.50-per-share cash acquisition of Pacira BioSciences after a tender offer drew 66.46% of shares, creating a wholly owned subsidiary in non-opioid pain management.
Topic
Topic
Viatris closed its $36.50-per-share cash acquisition of Pacira BioSciences after a tender offer drew 66.46% of shares, creating a wholly owned subsidiary in non-opioid pain management.